Related Experiment Video
Updated: Dec 6, 2025

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants
Jing Yan1, C Peter Bengtson1, Bettina Buchthal1
1Department of Neurobiology, Interdisciplinary Center for Neurosciences (IZN), Heidelberg University, 69120 Heidelberg, Germany.
Abstract:
Excitotoxicity induced by NMDA receptors (NMDARs) is thought to be intimately linked to high intracellular calcium load. Unexpectedly, NMDAR-mediated toxicity can be eliminated without affecting NMDAR-induced calcium signals. Instead, excitotoxicity requires physical coupling of NMDARs to TRPM4. This interaction is mediated by intracellular domains located in the near-membrane portions of the receptors. Structure-based computational drug screening using the interaction interface of TRPM4 in complex with NMDARs identified small molecules that spare NMDAR-induced calcium signaling but disrupt the NMDAR/TRPM4 complex. These interaction interface inhibitors strongly reduce NMDA-triggered toxicity and mitochondrial dysfunction, abolish cyclic adenosine monophosphate-responsive element-binding protein (CREB) shutoff, boost gene induction, and reduce neuronal loss in mouse models of stroke and retinal degeneration. Recombinant or small-molecule NMDAR/TRPM4 interface inhibitors may mitigate currently untreatable human neurodegenerative diseases.
Insights
NMDA receptor (NMDAR) toxicity is surprisingly not due to calcium but a physical link to TRPM4. Inhibiting this NMDAR/TRPM4 interaction protects neurons and may treat neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Excitotoxicity, driven by NMDA receptors (NMDARs), is traditionally linked to excessive intracellular calcium.
- However, NMDAR-mediated neurotoxicity can be prevented without altering NMDAR-induced calcium influx.
Purpose of the Study:
- To investigate the mechanism underlying NMDAR-mediated excitotoxicity.
- To identify therapeutic targets and develop small molecules to mitigate NMDAR-induced neurotoxicity.
- To explore the potential of targeting the NMDAR-TRPM4 interaction for treating neurodegenerative diseases.
Main Methods:
- Investigated the physical coupling between NMDARs and TRPM4 channels.
- Utilized structure-based computational drug screening to identify inhibitors of the NMDAR/TRPM4 interaction interface.
- Assessed the efficacy of identified inhibitors in cellular and mouse models of stroke and retinal degeneration.
Main Results:
- Excitotoxicity is dependent on the physical coupling of NMDARs to TRPM4, not solely on calcium signaling.
- Small molecules targeting the NMDAR/TRPM4 interface successfully disrupted the complex.
- Inhibitors reduced NMDA-triggered toxicity, mitochondrial dysfunction, CREB shutoff, and neuronal loss in disease models.
- Inhibitors preserved NMDAR-mediated calcium signaling while blocking toxicity.
Conclusions:
- The physical interaction between NMDARs and TRPM4 is a critical mediator of excitotoxicity.
- Targeting the NMDAR/TRPM4 interface with small molecules offers a promising therapeutic strategy.
- This approach may lead to treatments for currently intractable neurodegenerative conditions like stroke and retinal degeneration.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

